Month: August 2023

In this article SAGE BIIB Follow your favorite stocksCREATE FREE ACCOUNT In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images Shares of Sage Therapeutics fell more than 50% on Monday after the Food
0 Comments
This post may contain affiliate links. Read my disclosure policy. This quick and easy blender hummus made with canned chickpeas comes out super creamy. It’s so easy to make from scratch that you’ll never buy it pre-made again! Hummus The trick to making super creamy hummus without adding a ton of oil is using a
0 Comments
In this article GSK-GB GSK PFE Follow your favorite stocksCREATE FREE ACCOUNT Jun Li | Istock | Getty Images GlaxoSmithKline on Wednesday sued Pfizer in U.S. court, alleging patent infringement over Britain-based GSK’s respiratory syncytial virus vaccine.  GSK claims New York-based Pfizer’s RSV vaccine, Abrysvo, infringes on four of its patents related to the antigen
0 Comments
Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Revenue for the three months ended June 30 rose 13% year-over-year, to $26.75 billion, exceeding analysts’ estimates of $26.23 billion, according to Refinitiv. Adjusted earnings-per-share (EPS)
0 Comments
This post may contain affiliate links. Read my disclosure policy. A free 7-day, flexible weight loss meal plan including breakfast, lunch and dinner ideas and a shopping list. All recipes include macros and Weight Watchers points. Free 7 Day Healthy Meal Plan (August 7-13) As the peak of summer now fades behind us, lets soak up every second we can! Still have lots of
0 Comments
In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue.  The biotech company generated second-quarter sales of
0 Comments
Troubled Club holding Bausch Health Companies (BHC) reported better-than-expected quarterly results before the bell Thursday. However, it’s not nearly enough to get this stock out of the penalty box. Sales in the second quarter rose 10% to $2.17 billion, exceeding expectations of $2.04 billion, according to estimates compiled by Refinitiv. (On an organic basis —
0 Comments